Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms
- 4 August 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 178, 82-93
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (80873013)
This publication has 50 references indexed in Scilit:
- Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: NifedipineJournal of Pharmaceutical Sciences, 2015
- Structural Properties of Green Tea CatechinsThe Journal of Physical Chemistry B, 2015
- Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG6000 for compacted oral formulationsInternational Journal of Pharmaceutics, 2015
- Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin DrugsDrug Metabolism and Disposition, 2011
- PACKMOL: A package for building initial configurations for molecular dynamics simulationsJournal of Computational Chemistry, 2009
- The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionalsTheoretical Chemistry Accounts, 2007
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004
- Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvationJournal of the American Chemical Society, 1993
- The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errorsMolecular Physics, 1970